Laurent Metz

Ø Lead the development and implementation of health economics strategies and tactics for the umbrella markets: Western Europe, Scandinavia, Eastern and Central Europe, Russia. Middle East.
Ø Prepared reimbursement dossiers in collaboration with regional and local teams.
Ø Designed and implemented cost-minimization and cost-effectiveness models to support local product adoption.
Ø Implemented clinical and economic studies to generated outcome data and support local reimbursement submissions.
Ø Trained sales and marketing organizations on selling outcome data to expedite product adoption.
Ø Translated the impact of health care reforms on the Franchise business.
Ø Devised tools and processes to performed consistent reimbursement assessment on a worldwide basis.

Ø Proactively developed and implemented health economics and reimbursement strategies for Gynecare US in the hospital, outpatient and office-based sector.
Ø Devised specific strategies and tools to expand endometrial ablation treatments in the physician’s office.
Ø Provided early input to clinical protocol in the following disease areas (diagnosis and treatment of stress urinary incontinence, dysfunctional uterine bleeding, adhesions prevention, hysteroscopic surgery).
Ø Led the implementation of outcome research programs in dysfunctional uterine bleeding treatments.
Ø Built and developed relationships with key gynecologists specialized in coding.
Ø Established strategic partnerships with key customers to develop practice management approaches.
Ø Provided health economics and reimbursement leadership to the L&A and discovery team for go/no go decision in the following areas: diagnosis and treatment of urinary incontinence, uterine bleeding, adhesion prevention, breast and cervix cancer, tubal sterilization.
Ø Identified the need for the design, development and delivery of training materials to multiple audiences (Sales, marketing, senior management and board members).
Ø Coordinated the activities of the field reimbursement group.
- Developed and communicated tools that reflect the value proposition to payers and economic purchasers
- Analyze the impact of health care compliance issues on reimbursement for field support

Ø Led cross-functional teams to devise and implement global and regional pricing strategies and tactics.
Ø Communicated key findings to global marketing team and board members.
Ø Performed in-depth pricing studies for the US and the European markets for the launch of 2 breakthrough devices for the surgical treatment of prolapse and the diagnosis of urinary incontinence.
Ø Ensured timely and adequate delivery of all health economics and pricing elements over the product lifecycle.
Ø Devised financial model to assess local impact of the pricing strategy.
Ø Maintained knowledge of pricing and reimbursement requirements across major markets.
Ø Developed and managed European price policies to ensure consistent practice across business units.
Ø Designed and implemented trainings on value-based pricing for the marketing organizations and the senior management in Europe and Latin America.
Ø Worked with the regional Johnson & Johnson management on the implementation of health economics and reimbursement organization and processes in Latin America.
Ø Member of the Gynecare European board.

Ø Developed and implemented reimbursement strategies and tactics for the Ethicon Franchise in Europe.
Ø Successfully prepared and submitted Reimbursement Dossiers for local authorities
- Submission to the AFSSAPS (Agence francaise de securite sanitaire des produits de sante) in 2001.
THERMACHOICER, Balloon probe for the thermocoagulation of endometrium.
The Commission decided in favor of a strong improvement of clinical benefit (II) of THERMACHOICER compared to hysterectomy and endometrial resections
- Submission to the NICE (National Institute for Clinical Excellence) in 2001.
GYNECARE TVTR, Tension free vaginal tape for stress urinary incontinence
“The NICE recommended the tension-free vaginal tape as one of the range of surgical options for women with uncomplicated urodynamic stress incontinence in whom conservative treatment has failed”
THERMACHOICER, Balloon probe for the thermocoagulation of endometrium in 2002
“The NICE recommended that thermal balloon endometrial ablation and microwave endometrial ablation should be options for a women with heavy menstrual bleeding where surgery is an appropriate way to manage their bleeding “
Ø Performed in-depth reimbursement assessments in Europe in the following disease areas: urinary incontinence, dysfunctional uterine bleeding, surgical sterilization, general surgery, skin and wound closure, diagnosis of cervix cancer, surgical sealants, cardiac surgery, surgical oncology (ENT), orthopedic surgery
Ø Designed and implemented reimbursement and hospital dossiers for national authorities and economic purchasers in Europe.
Ø Led the design and implementation of several trainings in health economics, reimbursement and outcome research with the Stockholm School of economics for the Ethicon and Johnson & Johnson organizations.
Ø Active member of the Eucomed Funding and Reimbursement task force.

Ø Managed a portfolio of absorbable products (sutures and meshes) sales: 50 millions of Euros
Ø Launched successfully two new products:
- Dyed Monocryl, a suture for General surgery
- Durapatch, a mesh for dura matter replacement
Ø Accomplished successfully the transfer from Catgut to absorbable sutures after the Catgut ban in France.
Ø Increased the sales by 5 % after 1 year.

Ø Ran a business unit in Europe: 10 millions of Euros.
Ø Managed of team of 3 people.
Ø Devised and implemented marketing strategies to support local distributors.
Ø Meeting with international key opinion leaders to develop new products.
Ø Increased European sales by 15%.

Internship in Internal Medicine, Pediatrics, General Surgery, Surgical-Oncology